Arkolith/Insider Trading/LCTX/Form 4

Broadwood Capital Inc

10% OwnerLineage Cell Therapeutics, Inc. (LCTX) · full profile →Form 4 · filed Jan 28, 2025
Net Buying
Open-Market Buys
$6.0M
Open-Market Sells
$0
Net Open-Market Flow
$6.0M
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2025Buy(P)7.9M$0.76$6.0M49.6M
Jan 27, 2025Buy(P)0—$049.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 27, 2025Buy(P)7.9M—$07.9M
Jan 27, 2025Buy(P)0—$07.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-25-000555) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML